Security
Sonoma Pharmaceuticals, Inc. Common Stock · SNOA
SNOANASDAQCommon stockCurrentCIK 1367083Updated Nov 14, 2026
Name history
Oculus Innovative Sciences, Inc. · through Dec 2, 2016
SNOA price & chart
Loading TradingView…
NASDAQ:SNOA on TradingView ↗About the company
Sonoma Pharmaceuticals is a global scientific healthcare company that pioneered the use of hypochlorous acid (HOCl) in the specialty pharmaceutical sector with over 20 years of experience developing and manufacturing HOCl products. We develop safe and effective solutions that provide fast relief and are free from side effects and other limitations. Our primary focus is developing innovative solutions for dermatological conditions, wound care, eye care, podiatry, animal health care and non-toxic disinfectants. Our products are clinically proven to reduce itch, pain, scarring, and irritation safely and without damaging healthy tissue. We believe our products, which are sold throughout the United States and internationally, have improved outcomes for millions of patients with skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain and harmful inflammatory responses, without a single report of serious adverse effect.
In the news
No coverage from other publishers is available.
SEC disclosures
Sonoma Pharmaceuticals, Inc. files 8-K: Material Event ↗
Recent filings
S-3 filing
10-Q filing
8-A12B/A filing
Entry into a Material Definitive Agreement · Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 1.01, 3.03, 5.03, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 13,623,000Source | 13,668,000Source | 14,618,000Source | 13,856,000Source | 13,685,000Source | 18,107,000Source | 14,594,000Source | 13,673,000Source | 13,960,000Source | 13,693,000Source | 14,740,000Source | 16,231,000Source |
| Property, Plant and Equipment, NetUSD | 314,000Source | 215,000Source | 397,000Source | 284,000Source | 255,000Source | 290,000Source | 301,000Source | 302,000Source | 310,000Source | 225,000Source | 365,000Source | 488,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,561,000Source | 5,236,000Source | 2,406,000Source | 3,035,000Source | 4,078,000Source | 5,338,000Source | 3,605,000Source | 2,589,000Source | 2,399,000Source | 5,374,000Source | 3,128,000Source | 3,820,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,382,000Source | 2,405,000Source | 2,876,000Source | 2,703,000Source | 3,157,000Source | 3,182,000Source | 2,602,000Source | 3,247,000Source | 2,527,000Source | 2,232,000Source | 2,898,000Source | 2,572,000Source |
| Inventory, NetUSD | 3,703,000Source | 3,143,000Source | 2,955,000Source | 3,634,000Source | 2,837,000Source | 3,786,000Source | 3,802,000Source | 2,658,000Source | 3,651,000Source | 2,915,000Source | 2,719,000Source | 2,858,000Source |
| Assets, CurrentUSD | 12,145,000Source | 12,380,000Source | 12,502,000Source | 12,501,000Source | 12,221,000Source | 16,268,000Source | 13,107,000Source | 11,927,000Source | 12,100,000Source | 12,648,000Source | 12,548,000Source | 13,798,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,351,000Source | 1,387,000Source | 4,009,000Source | 2,925,000Source | 1,929,000Source | 3,962,000Source | 2,868,000Source | 3,196,000Source | 3,436,000Source | 1,915,000Source | 3,541,000Source | 4,308,000Source |
| Operating Lease, Right-of-Use AssetUSD | 642,000Source | 119,000Source | 341,000Source | 479,000Source | 162,000Source | 578,000Source | 536,000Source | 216,000Source | 602,000Source | 84,000Source | 286,000Source | 418,000Source |
| Other Assets, NoncurrentUSD | 64,000Source | 73,000Source | 78,000Source | 84,000Source | 76,000Source | 66,000Source | 80,000Source | 61,000Source | 64,000Source | 74,000Source | 66,000Source | 73,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 10,191,000Source | 8,798,000Source | 7,926,000Source | 10,069,000Source | 8,333,000Source | 11,513,000Source | 10,538,000Source | 8,698,000Source | 10,865,000Source | 9,282,000Source | 8,603,000Source | 8,254,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 2,000Source | 0Source | 0Source | 0Source | 0Source | 2,000Source | 0Source | 0Source | 2,000Source | 5,000Source |
| Retained Earnings (Accumulated Deficit)USD | -200,400,000Source | -197,030,000Source | -193,282,000Source | -199,581,000Source | -196,102,000Source | -201,311,000Source | -199,047,000Source | -195,492,000Source | -200,981,000Source | -197,806,000Source | -194,349,000Source | -189,514,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -3,191,000Source | -4,554,000Source | -2,823,000Source | -3,365,000Source | -4,197,000Source | -3,008,000Source | -3,570,000Source | -3,604,000Source | -3,243,000Source | -4,376,000Source | -2,723,000Source | -3,418,000Source |
| Stockholders' Equity Attributable to ParentUSD | 3,432,000Source | 4,870,000Source | 6,692,000Source | 3,787,000Source | 5,352,000Source | 6,594,000Source | 4,056,000Source | 4,975,000Source | 3,095,000Source | 4,411,000Source | 6,137,000Source | 7,977,000Source |
| Additional Paid in Capital, Common StockUSD | 207,023,000Source | 206,454,000Source | 202,795,000Source | 206,733,000Source | 205,651,000Source | 210,913,000Source | 206,673,000Source | 204,069,000Source | 207,319,000Source | 206,593,000Source | 203,207,000Source | 200,904,000Source |
| Liabilities and EquityUSD | 13,623,000Source | 13,668,000Source | 14,618,000Source | 13,856,000Source | 13,685,000Source | 18,107,000Source | 14,594,000Source | 13,673,000Source | 13,960,000Source | 13,693,000Source | 14,740,000Source | 16,231,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 4,217,000Source | 3,703,000Source | 3,074,000Source | 4,322,000Source | 3,309,000Source | 5,447,000Source | 4,848,000Source | 3,751,000Source | 4,832,000Source | 4,096,000Source | 3,719,000Source | 3,717,000Source |
| Operating Lease, Liability, CurrentUSD | 146,000Source | 90,000Source | 181,000Source | 88,000Source | 116,000Source | 160,000Source | 96,000Source | 155,000Source | 151,000Source | 58,000Source | 198,000Source | 256,000Source |
| Accounts Payable, CurrentUSD | 1,646,000Source | 1,395,000Source | 864,000Source | 1,404,000Source | 770,000Source | 2,191,000Source | 2,046,000Source | 751,000Source | 1,923,000Source | 953,000Source | 607,000Source | 841,000Source |
| Operating Lease, Liability, NoncurrentUSD | 509,000Source | 29,000Source | 160,000Source | 391,000Source | 46,000Source | 439,000Source | 440,000Source | 61,000Source | 469,000Source | 27,000Source | 87,000Source | 162,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Revenue, CurrentUSD | 314,000Source | 302,000Source | 75,000Source | 750,000Source | 319,000Source | 282,000Source | 731,000Source | 413,000Source | 284,000Source | 641,000Source | 478,000Source | 100,000Source |
| Deferred Revenue, NoncurrentUSD | 0Source | 30,000Source | 101,000Source | 0Source | 45,000Source | — | 4,000Source | 64,000Source | 0Source | 17,000Source | 87,000Source | 140,000Source |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | -2,910,000Source | -4,923,000Source | -5,182,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 32,000Source | 36,000Source | 139,000Source | 138,000Source | 176,000Source | 125,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 24,000Source | 13,000Source | 39,000Source | 14,000Source | 58,000Source | 57,000Source | 255,000Source | 224,000Source | 516,000Source | 669,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 650,000Source | 216,000Source | 122,000Source | -434,000Source | 230,000Source | -62,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 81,000Source | 652,000Source | 465,000Source | 388,000Source | -184,000Source | 0Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 244,000Source | -550,000Source | -196,000Source | -33,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -649,000Source | -2,015,000Source | -3,933,000Source | -88,000Source | -2,398,000Source | -6,152,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -2,000Source | -106,000Source | -192,000Source | -80,000Source | -2,000Source | -258,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 2,000Source | 106,000Source | 192,000Source | 80,000Source | 17,000Source | 269,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,454,000Source | -58,000Source | 477,000Source | 3,030,000Source | 1,676,000Source | 2,489,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 774,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 2,939,000Source | -1,769,000Source | -2,975,000Source | 2,246,000Source | -692,000Source | -3,576,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 2,561,000Source | 5,236,000Source | 3,035,000Source | 4,078,000Source | 5,338,000Source | 3,605,000Source | 2,399,000Source | 5,374,000Source | 3,128,000Source | 3,820,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 3,000Source | 3,000Source | 6,000Source | 11,000Source | 22,000Source | 17,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 136,000Source | 410,000Source | 673,000Source | -616,000Source | 32,000Source | 345,000Source |
| Additional Financial Items | ||||||||||||
| DepreciationUSD | — | — | — | — | — | — | — | — | 139,000Source | 138,000Source | — | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | — | — | — | 1,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 1,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Income Tax Expense (Benefit)USD | — | — | -130,000Source | 9,000Source | -197,000Source | 147,000Source | 0Source | -1,000Source | -244,000Source | 550,000Source | -196,000Source | -33,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -819,000Source | -928,000Source | -534,000Source | -610,000Source | -330,000Source | -1,241,000Source | -3,175,000Source | -3,457,000Source | -4,835,000Source | -5,151,000Source |
| Operating ExpensesUSD | — | — | 2,328,000Source | 2,301,000Source | 2,457,000Source | 2,211,000Source | 2,617,000Source | 2,559,000Source | 9,876,000Source | 9,175,000Source | 9,446,000Source | 9,047,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -271,000Source | 112,000Source | -394,000Source | 387,000Source | -290,000Source | -147,000Source | -958,000Source | 803,000Source | -330,000Source | -631,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 3,536,000Source | 0Source | 427,000Source | 3,079,000Source | 1,784,000Source | 2,868,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 0Source | 23,000Source | 44,000Source | 82,000Source | — | 0Source |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 4,349,000Source | 3,564,000Source | 5,604,000Source | 3,579,000Source | 6,406,000Source | 4,015,000Source | 19,529,000Source | 14,288,000Source | 12,735,000Source | 13,272,000Source |
| Cost of RevenueUSD | — | — | 2,699,000Source | 2,294,000Source | 3,484,000Source | 2,218,000Source | 3,829,000Source | 2,551,000Source | 12,114,000Source | 8,823,000Source | 7,990,000Source | 8,795,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 1,771,000Source | 1,874,000Source | 1,882,000Source | 1,705,000Source | 2,020,000Source | 1,965,000Source | 7,605,000Source | 7,361,000Source | 7,575,000Source | 8,840,000Source |
| Operating Income (Loss)USD | — | — | -678,000Source | -1,031,000Source | -337,000Source | -850,000Source | -40,000Source | -1,095,000Source | -2,461,000Source | -3,710,000Source | -4,701,000Source | -4,570,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -949,000Source | -919,000Source | -731,000Source | -463,000Source | -330,000Source | -1,242,000Source | -3,419,000Source | -2,907,000Source | -5,031,000Source | -5,184,000Source |
| Income Tax Expense (Benefit)USD | — | — | -130,000Source | 9,000Source | -197,000Source | 147,000Source | 0Source | -1,000Source | -244,000Source | 550,000Source | -196,000Source | -33,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -819,000Source | -928,000Source | -534,000Source | -610,000Source | -330,000Source | -1,241,000Source | -3,175,000Source | -3,457,000Source | -4,835,000Source | -5,151,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.48Source | -0.63Source | -0.32Source | -0.59Source | -0.09Source | -0.76Source | -1.89Source | -2.79Source | -0.53Source | -1.52Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.48Source | -0.63Source | -0.32Source | -0.59Source | -0.09Source | -0.76Source | -1.89Source | -2.79Source | -0.53Source | -1.52Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,713,000Source | 1,464,000Source | 1,646,000Source | 1,034,000Source | 3,846,000Source | 1,641,000Source | 1,684,000Source | 1,241,000Source | 9,090,000Source | 3,394Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,713,000Source | 1,464,000Source | 1,646,000Source | 1,034,000Source | 3,846,000Source | 1,641,000Source | 1,684,000Source | 1,241,000Source | 9,090,000Source | 3,394Source |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 2,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | — | — | 139,000Source | 138,000Source | 176,000Source | 125,000Source |
| Gross ProfitUSD | — | — | 1,650,000Source | 1,270,000Source | 2,120,000Source | 1,361,000Source | 2,577,000Source | 1,464,000Source | 7,415,000Source | 5,465,000Source | 4,745,000Source | 4,477,000Source |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | — | — | 16,000Source |
| Operating ExpensesUSD | — | — | 2,328,000Source | 2,301,000Source | 2,457,000Source | 2,211,000Source | 2,617,000Source | 2,559,000Source | 9,876,000Source | 9,175,000Source | 9,446,000Source | 9,047,000Source |
| Other Operating Income (Expense), NetUSD | — | — | -271,000Source | 112,000Source | -394,000Source | 387,000Source | -290,000Source | -147,000Source | -958,000Source | 803,000Source | -330,000Source | -631,000Source |
| Research and Development ExpenseUSD | — | — | 557,000Source | 427,000Source | 575,000Source | 506,000Source | 597,000Source | 594,000Source | 2,271,000Source | 1,814,000Source | 1,871,000Source | 207,000Source |
Offerings
Registration 333-300043
Registration 333-295171
- Gross proceeds
- 3999998.0
- Net proceeds
- 3699999.0
- Deal price
- 1.35
- Shares
- 2962961
- Offering price
- $1.35
- Ticker
- SNOA
Underwriters: Dawson James Securities, Inc.
Filing attachments
sonoma_ex107.htm · S-8 · 2026-07-09
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-8 SONOMA PHARMACEUTICALS, INC. Table 1: Newly Registered Securities Security Type Security Class Title Notes Fee Calculation Amount Registered Proposed Maximum Offering Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee …
Read attachment ↗